A detailed history of Cutler Group LP transactions in Deciphera Pharmaceuticals, Inc. stock. As of the latest transaction made, Cutler Group LP holds 300 shares of DCPH stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Previous 500 40.0%
Holding current value
$0
Previous $8,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$13.58 - $17.36 $2,716 - $3,472
-200 Reduced 40.0%
300 $4,000
Q4 2023

Jan 18, 2024

SELL
$10.11 - $16.54 $1,011 - $1,654
-100 Reduced 16.67%
500 $8,000
Q1 2023

May 01, 2023

SELL
$14.26 - $22.1 $2,852 - $4,420
-200 Reduced 25.0%
600 $9,000
Q4 2022

Feb 07, 2023

BUY
$14.85 - $19.04 $4,455 - $5,712
300 Added 60.0%
800 $13,000
Q3 2022

Oct 25, 2022

SELL
$12.38 - $20.23 $16,094 - $26,299
-1,300 Reduced 72.22%
500 $9,000
Q2 2022

Aug 04, 2022

SELL
$9.11 - $13.98 $13,665 - $20,970
-1,500 Reduced 45.45%
1,800 $23,000
Q1 2022

Apr 14, 2022

SELL
$6.87 - $11.11 $7,557 - $12,221
-1,100 Reduced 25.0%
3,300 $30,000
Q4 2021

Jan 18, 2022

SELL
$7.7 - $37.13 $2,310 - $11,139
-300 Reduced 6.38%
4,400 $42,000
Q3 2021

Oct 26, 2021

SELL
$26.46 - $37.15 $80,703 - $113,307
-3,050 Reduced 39.35%
4,700 $159,000
Q2 2021

Jul 19, 2021

BUY
$32.73 - $47.95 $80,221 - $117,525
2,451 Added 46.25%
7,750 $283,000
Q1 2021

Apr 26, 2021

BUY
$40.39 - $56.73 $145,404 - $204,228
3,600 Added 211.89%
5,299 $237,000
Q4 2020

Jan 21, 2021

SELL
$51.77 - $66.18 $56,947 - $72,798
-1,100 Reduced 39.3%
1,699 $96,000
Q3 2020

Oct 27, 2020

SELL
$43.8 - $58.16 $39,420 - $52,344
-900 Reduced 24.33%
2,799 $143,000
Q2 2020

Jul 22, 2020

SELL
$37.05 - $65.03 $8,076 - $14,176
-218 Reduced 5.57%
3,699 $220,000
Q1 2020

May 07, 2020

SELL
$33.63 - $69.4 $933,030 - $1.93 Million
-27,744 Reduced 87.63%
3,917 $161,000
Q4 2019

Feb 06, 2020

BUY
$31.7 - $69.93 $997,313 - $2.2 Million
31,461 Added 15730.5%
31,661 $1.97 Million
Q3 2019

Oct 28, 2019

BUY
$19.95 - $38.85 $3,990 - $7,770
200 New
200 $6,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.